Form 8-K - Current report:
SEC Accession No. 0001193125-26-220671
Filing Date
2026-05-13
Accepted
2026-05-13 08:15:06
Documents
12
Period of Report
2026-05-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d10320d8k.htm   iXBRL 8-K 29947
2 EX-10.1 d10320dex101.htm EX-10.1 41470
  Complete submission text file 0001193125-26-220671.txt   201844

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA spry-20260512.xsd EX-101.SCH 3174
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20260512_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20260512_pre.xml EX-101.PRE 11257
15 EXTRACTED XBRL INSTANCE DOCUMENT d10320d8k_htm.xml XML 3643
Mailing Address 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 26971021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)